Artelo Biosciences ARTL
NASDAQ ARTL
$2.57 -0.05 (-1.91%)
As of: Oct 21, 2026 · 3:59 PM EDT

Artelo Biosciences (ARTL) Debt Ratio (2017 - 2025)

Updated

Artelo Biosciences' (ARTL) Debt Ratio came in at 0.16 for Q4 2025, down 23.9% from the prior quarter.

Analysis

Artelo Biosciences (ARTL) Debt Ratio (2017 - 2025) Analysis & Trends

Since Q2 2017, Artelo Biosciences has reported Debt Ratio for 4 quarters.

  • The Q4 2025 figure stands as the lowest quarterly Debt Ratio since Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Artelo Biosciences 52,106.49 -5.08 Mn - 0.16
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.16
Sep 30, 2025 0.21
May 31, 2017 0.13
Feb 28, 2017 2.20
API Access

Artelo Biosciences Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ARTL&period=max&api_key=YOUR_API_KEY